Gabe Newell Co-Founded a Neuroscience Company in 2019 and Its First Brain Chip Is Expected to Ship Later This Year
- Gabe Newell, Valve's CEO, co-founded Starfish Neuroscience in 2022 to develop brain-computer interface technology, including a brain chip expected in late 2025.
- Newell's interest in BCIs began around 2019 when Valve explored gaming applications, leading to incorporating Starfish to advance minimally invasive neural interfaces.
- Starfish's wireless neural implant, produced using TSMC's 55-nanometer technology, features 32 electrodes that enable simultaneous recording and stimulation across multiple brain areas.
- Engineer Nate Cermak mentioned that they see potential to create a novel category of neural interfaces that are minimally invasive and distributed, allowing simultaneous interaction with multiple areas of the brain.
- If successful, Starfish's technology could enable new treatments for neurological conditions and open collaboration opportunities, though significant development work remains.
18 Articles
18 Articles
Gabe Newell’s Company Aims to Manufacture Brain Chip Implants
TECH NEWS – No, not Valve. We’re talking about another company founded by Gabe Newell in 2019. It has come to light that Valve boss Gabe Newell is also the co-founder of Starfish, a neuroscience company working on a broad range of foundational technologies to enable new ways of interacting with the brain. If all goes as planned, the first neural interface chip could reach the market by the end of 2025. Brain interfaces are not a new area of in…
Valve CEO Expresses Interest in Brain Chip Implants
Valve co-founder and CEO Gabe Newell is behind a new startup, Starfish Technologies, which plans to release brain-computer interface (BCI) chips as early as this year. While Valve is known for hit game series like Half-Life, Portal, and Counter-Strike, these new chips are not aimed at gaming — at least for now. Instead, Starfish envisions the technology primarily for medical use, targeting neurological disorders such as Parkinson’s disease, in a…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage